跳到主要內容

Wagner Charles F Jr 的 Form 4 申報

Vertex Pharmaceuticals Inc(VRTX),2023/3/14 申報

申報編號
0001209191-23-018460
申報時間
2023/3/14
交易日
2023/3/10-3/13
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 14 筆非衍生性交易。公開市場賣出合計 $138.8 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Wagner Charles F JrCIK 0001223348高階主管(執行副總裁、財務長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/3/10Common StockS賣出處分−361$286.64F2,F3−$103,477.0457,772直接
2023/3/10Common StockS賣出處分−515$287.83F2,F4−$148,232.4557,257直接
2023/3/10Common StockS賣出處分−327$288.91F2,F5−$94,473.5756,930直接
2023/3/10Common StockS賣出處分−30$289.44−$8,683.256,900直接
2023/3/10Common StockS賣出處分−541$291.47F2,F6−$157,685.2756,359直接
2023/3/10Common StockS賣出處分−185$292.68F2,F7−$54,145.856,174直接
2023/3/10Common StockS賣出處分−27$293.61−$7,927.4756,147直接
2023/3/10Common StockS賣出處分−102$294.94F2,F8−$30,083.8856,045直接
2023/3/13Common StockS賣出處分−24$288.31−$6,919.4456,021直接
2023/3/13Common StockS賣出處分−420$292.41F2,F9−$122,812.255,061直接
2023/3/13Common StockS賣出處分−1,153$293.35F2,F10−$338,232.5554,448直接
2023/3/13Common StockS賣出處分−715$294.52F2,F11−$210,581.853,733直接
2023/3/13Common StockS賣出處分−292$295.89F2,F12−$86,399.8853,441直接
2023/3/13Common StockS賣出處分−62$296.77−$18,399.7453,379直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

表 I 有 10 筆交易的價格引用這則附註。

F3

Open market sales reported on this line occurred at a weighted average price of $286.64 (range $286.17 to $287.16).

表 I 有 1 筆交易的價格引用這則附註。

F4

Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.30 to $288.20).

表 I 有 1 筆交易的價格引用這則附註。

F5

Open market sales reported on this line occurred at a weighted average price of $288.91 (range $288.37 to $289.34).

表 I 有 1 筆交易的價格引用這則附註。

F6

Open market sales reported on this line occurred at a weighted average price of $291.47 (range $291.10 to $292.00).

表 I 有 1 筆交易的價格引用這則附註。

F7

Open market sales reported on this line occurred at a weighted average price of $292.68 (range $292.14 to $293.12).

表 I 有 1 筆交易的價格引用這則附註。

F8

Open market sales reported on this line occurred at a weighted average price of $294.94 (range $294.85 to $295.35).

表 I 有 1 筆交易的價格引用這則附註。

F9

Open market sales reported on this line occurred at a weighted average price of $292.41 (range $291.97 to $292.82).

表 I 有 1 筆交易的價格引用這則附註。

F10

Open market sales reported on this line occurred at a weighted average price of $293.35 (range $292.99 to $293.80).

表 I 有 1 筆交易的價格引用這則附註。

F11

Open market sales reported on this line occurred at a weighted average price of $294.52 (range $294.13 to $294.81).

表 I 有 1 筆交易的價格引用這則附註。

F12

Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.33 to $296.32).

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)